Product Information
QC DICLOFENAC SODIUM 1% GEL is a generic product labeled by Chain Drug Marketing Association, priced at $0.0813 per GM under NDC 83324030601. Its NADAC has been published 95 times since Dec 11, 2024.
FDA first approved this application on Mar 18, 2016.
Strength
10 mg/g
Manufacturer
Chain Drug Marketing AssociationNDC
83324030601
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208077FDA Approved
3/18/2016
On Market Since
8/1/2024
Pharmacological Classes
Price Statistics
The NADAC for QC DICLOFENAC SODIUM 1% GEL has been published 95 times since Dec 11, 2024, and over the history we have for it it has risen 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0813 per GM |
|---|---|
| All-time high | $0.0953 (Jan 14, 2026) |
| All-time low | $0.0796 (Dec 11, 2024) |
| 52-week high | $0.0953 |
| 52-week low | $0.0813 |
| Median price | $0.0903 |
| Average price | $0.0895 |
| Largest weekly change | +6.8% (Dec 18, 2024) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC DICLOFENAC SODIUM 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for QC DICLOFENAC SODIUM 1% GEL, manufactured by Chain Drug Marketing Association, is $0.0813 per GM (NDC 83324030601), effective Sep 30, 2026.
How has the price of QC DICLOFENAC SODIUM 1% GEL changed over time?
Over the history we have for it, the NADAC for QC DICLOFENAC SODIUM 1% GEL has risen 2.1%. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for QC DICLOFENAC SODIUM 1% GEL?
Since Dec 11, 2024, the NADAC for QC DICLOFENAC SODIUM 1% GEL has ranged from a low of $0.0796 (Dec 11, 2024) to a high of $0.0953 (Jan 14, 2026), with a median of $0.0903 per GM.
Are there cheaper alternatives to QC DICLOFENAC SODIUM 1% GEL?
No other NADAC-published product currently shares the active ingredient and strength of QC DICLOFENAC SODIUM 1% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC DICLOFENAC SODIUM 1% GEL?
QC DICLOFENAC SODIUM 1% GEL (NDC 83324030601) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.